DMAC vs SPCE · $157.4M cap vs rev $7.0M
DiaMedica Therapeutics Inc (DMAC) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
DMAC does not have a complete income-statement cache yet.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
DMAC currently screens at market cap $157.4M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the DMAC and SPCE stock pages for the full models.
Not investment advice.